AbbVie Earnings Beat, Revenue Misses In Q1
2022.04.29 15:01
AbbVie Earnings Beat, Revenue Misses In Q1
Investing.com – AbbVie (NYSE:ABBV) reported on Friday first quarter earnings that beat analysts’ forecasts and revenue that fell short of expectations.
AbbVie announced earnings per share of $3.16 on revenue of $13.54B. Analysts polled by Investing.com anticipated EPS of $3.14 on revenue of $13.67B.
AbbVie shares are down 14.31% from the beginning of the year, still down 11.14% from its 52 week high of $175.91 set on April 8. They are under-performing the S&P 500 which is down 10.04% from the start of the year.
AbbVie shares gained 0.99% in pre-market trade following the report.
AbbVie follows other major Healthcare sector earnings this month
AbbVie’s report follows an earnings beat by UnitedHealth on April 14, who reported EPS of $5.49 on revenue of $80.15B, compared to forecasts EPS of $5.36 on revenue of $78.73B.
J&J had beat expectations on April 19 with first quarter EPS of $2.67 on revenue of $23.43B, compared to forecast for EPS of $2.59 on revenue of $23.62B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
